High doses of Haldol in the treatment of 5 young schizophrenics in a therapeutic community.
Even within a unique setting with high-powered and board-spectrum therapeutic tools, acute agitation can pose a serious problem. In this communication we review the cases of five schizophrenic adolescents whose agitation created a threat to themselves and the therapeutic community. The institute tried a variety of psychotherapeutic and chemotherapeutic approaches to no avail and only as last resort we used Haldol in very high doses. Since research centers which specialise in the study of schizophrenic persons and their families rarely publish about chemotherapy in high doses, it seems worthwhile relating our findings.
D000293:Adolescent; D000328:Adult; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy*; D013808:Therapeutic Community
D006220:Haloperidol